Floatz logo

Vildagliptin

Metabolic Syndrome

Cairo UniversitySmall moleculePhase 4 / ApprovedDormant
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
73/ 100

Competitive context

44 Active assets in the Metabolic Syndrome cohort.

Asset / SponsorPhaseRating
Lipitor
Seoul National University Hospital
Phase 4BBB
Topamax
All India Institute of Medical Sciences, Bhubaneswar
Phase 4BBB
Rosuvastatin
Dr. B. Catharine. Craven
Phase 4BBB
Pioglitazone
Philip Kern
Phase 4BBB
SIMVASTATIN
Jaime Daniel Mondragon
Phase 4BBB

View all 50 →

Same molecule, other indications

Vildagliptin is also rated in:

type 2 diabetes mellitusDormant
BBB
Indicative ·
72 / 100
View asset →
inflammatory diseaseDormant
BB
Indicative ·
69 / 100
View asset →
kidney failureDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →